Arranz, J, Lantero-Rodriguez, J, Braun-Wohlfahrt, LS, Vaqué-Alcázar, L, Rodriguez-Baz, I, Kac, PR, Arslan, B, Maure-Blesa, L, Pertierra, L, Videla, L, Carmona-Iragui, M, Benejam, B, Soriano, LD, Barroeta, I, Fernández, S, Bejanin, A, Lleó, A, Ashton, NJ, Zetterberg, H, Fortea, J, Alcolea, D, Montoliu-Gaya, L. CSF and plasma tau biomarkers in the Down syndrome-Alzheimer's disease continuum. EBioMedicine. 2026; 130DOI:10.1016/j.ebiom.2026.106370. PMID:42435584. IF:10.800(Q1/1D).

Serra-Blasco, M, Miquel-Giner, N, Vicent-Gil, M, Porta-Casteràs, D, Martínez-Zalacaín, I, Cano, M, de la Peña-Arteaga, V, Mar-Barrutia, L, Alemany-Navarro, M, Soriano-Mas, C, Lopez-Solà, M, Andrews-Hanna, JR, Portella, MJ, Soler, J, Cardoner, N, Alonso, P, Lopez-Solà, C. Clinical and Neuroimaging Effects of Mindfulness-Based Cognitive Therapy for Symptomatic Obsessive-Compulsive Disorder Patients after First-Line Treatments: A Randomised Controlled Trial. PSYCHOTHERAPY AND PSYCHOSOMATICS. 2026; 95(4)DOI:10.1159/000548961. PMID:41115123. IF:17.400(Q1/1D).

Baena, AMG, Mir, MC, Faja, GV, Osorio, LJM, Vilaseca, VG. Inflammatory myopathies with anti-TIF1y antibodies and their association with neoplasms: a study of a series of 28 cases. MEDICINA CLINICA. 2026; 166(8)DOI:10.1016/j.medcli.2026.107496. PMID:. IF:2.100(Q2/3D).

Slusarczyk, A, Moschini, M, Krajewski, W, Scilipoti, P, Velasco, JC, Mertens, LS, Mori, K, Subiela, JD, Garbas, K, Duran, PD, Claps, F, Contieri, R, Domanski, P, Tully, K, Grobet-Jeandin, E, Puentedura, AL, Lijnen, RAG, Fertitta, G, Longoni, M, Del Giudice, F, Gallioli, A, Laukhtina, E, Marcq, G, Mari, A, Amodeo, A, Afferi, L, Albisinni, S, Boorjian, SA, Soria, F, Briganti, A, Shariat, SF, Gontero, P, Radziszewski, P, Pradere, B. Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer. ANNALS OF SURGICAL ONCOLOGY. 2026; 33(8)DOI:10.1245/s10434-026-19476-6. PMID:41862762. IF:3.500(Q1/2D).

Gonzalez, JA, Sebio, A, Martin-Broto, J, Hindi, N, Villarejo-Campos, P, Jiménez, M, Díaz-Beveridge, R, Castellanos, JFO, Andújar, RL, Alvarez, RA, Asencio, JM, Serrano, C, Conde, NR, Boix, SC, Krauel, L, Codina, HC, García, JAT, de Llanos, EL, Ninou, AH, Campos, AP, Gruber, AK, Pousa, AL. ASO Visual Abstract: First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas. ANNALS OF SURGICAL ONCOLOGY. 2026; 33(8)DOI:10.1245/s10434-026-19614-0. PMID:41984420. IF:3.500(Q1/2D).

Gonzalez, JA, Sebio, A, Martin-Broto, J, Hindi, N, Villarejo-Campos, P, Jiménez, M, Díaz-Beveridge, R, Castellanos, JFO, Andújar, RL, Alvarez, RA, Asencio, JM, Serrano, C, Conde, NR, Boix, SC, Krauel, L, Codina, HC, García, JAT, de Llanos, EL, Ninou, AH, Campos, AP, Gruber, AK, Pousa, AL. First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas. ANNALS OF SURGICAL ONCOLOGY. 2026; 33(8)DOI:10.1245/s10434-026-19487-3. PMID:41998462. IF:3.500(Q1/2D).

Di Grazia, G, Di Lauro, V, Morchón-Araujo, D, Nucera, S, Figuero-Pérez, L, Calleja-Holgado, FJ, Sánchez, DP, Wallbaum, B, Vargas, PR, Palleschi, M, Musolino, A, Cobos, GZ, Paradis, AL, Barroso, G, Cano, OC, Portulas, ED, Caltavituro, A, Buono, G, Gillaranz, YJ, Echavarria, I, López-Tarruella, S, Sirvén, MB, Martinez-Sáez, O, Adamo, B, Mun, M, Arpino, G, Bayona, RS, De Laurentiis, M, Rodriguez, CA, Pascual, T, Losada, MV, Schettini, F. Association between chemotherapy use and prognosis in young patients with stage I-II ER+/HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching (vol 242 , 116818 , 2026 ). EUROPEAN JOURNAL OF CANCER. 2026; 243DOI:10.1016/j.ejca.2026.116852. PMID:42250453. IF:7.100(Q1/2D).

Ahrens, M, Haanen, J, Albiges, L, Goupil, MG, Boleti, E, Gravis, G, Fléchon, A, Grimm, MO, Bedke, J, Barthélémy, P, Castellano, D, Mellado, B, Ivanyi, P, Rottey, S, Flörcken, A, Suárez, C, Maroto, JP, Grünwald, V, Oosting, S, Kopecky, J, Zschäbitz, S, Boegemann, M, Buchler, T, Niegisch, G, Goebell, PJ, Waddell, T, Joly, F, Priou, F, Retz, M, Siemer, S, Zimmermann, U, Deckbar, D, Burkholder, I, Hartmann, A, Bergmann, L. Papillary renal cell carcinoma-exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review. EUROPEAN JOURNAL OF CANCER. 2026; 243DOI:10.1016/j.ejca.2026.116816. PMID:42235464. IF:7.100(Q1/2D).

Acosta, L, Soldevila, N, Torner, N, Avellon, A, Hernando, V, Borras, E, Martínez, A, Pericas, C, Rius, C, Godoy, P, Dominguez, A. Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression (Vol 21, e0329751, 2026). PLoS One. 2026; 21(7)DOI:10.1371/journal.pone.0354253. PMID:. IF:2.600(Q2/4D).

Lozano-Rivas, N, Rúa-Figueroa, I, Freire-González, M, Turrión, A, Castellvi, I, Ajo, JB, Calvo-Alén, J, Ortego-Centeno, N, Díaz-Encarnación, M, Pego-Reigosa, JM, Ding, B, Galvez-Fernandez, M, Bahamontes-Rosa, N, Cervera, R. Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort. Lupus Science & Medicine. 2026; 13(2)DOI:10.1136/lupus-2026-002054. PMID:42463277. IF:3.500(Q2/3D).

Tapia, JC, Gavira, J, Matthews, D, Santoni, M, Young, M, Blondel, L, Flippot, R, Frazer, R, Anguera, G, Maroto, P. International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal. INTERNATIONAL JOURNAL OF CANCER. 2026; 159(2)DOI:10.1002/ijc.70379. PMID:41653082. IF:4.700(Q1/3D).

dos Santos, BG, Brisnovali, NF, Haney, C, Coven, M, Sebzevari, HL, Gaebel, L, Zhang, XB, Sun, JAT, Canfrán-Duque, A, Rotllan, N, Nasiri, A, Kahn, M, McAlpine, CS, Shulman, GI, Goedeke, L. A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice. Science Translational Medicine. 2026; 18(858)DOI:10.1126/scitranslmed.adv1815. PMID:42455898. IF:14.600(Q1/1D).

Ceriello, C, Torres, OH, Rubio-Guerra, S, García-Castro, J, Selma-Gonzalez, J, Sala, I, Sánchez-Saudinós, MB, Videla, L, Vera-Campuzano, E, Arranz, J, Rodríguez-Baz, I, Maure-Blesa, L, Dols-Icardo, O, Valldeneu, S, Barroeta, I, Santos-Santos, M, Carmona-Iragui, M, Vaqué-Alcázar, L, Alvarez-Sanchez, E, Lorente, O, Carreras, M, Bejanin, A, Belbin, O, Lleó, A, Fortea, J, Alcolea, D, Illán-Gala, I. Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old. NEUROLOGY. 2026; 107(1)DOI:10.1212/WNL.0000000000218180. PMID:42308436. IF:8.500(Q1/1D).

Allen, JA, Eftimov, F, Querol, L, Sommer, C, Dimachkie, MM, Fix, C, Gable, K, Gorson, KC, Harbo, T, Karam, C, Koike, H, Kuitwaard, K, Lunn, MP, Nobile-Orazio, E, Pasnoor, M, Rajabally, YA, Peric, S, Reisin, R, Butler, L. Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy. NEUROLOGY. 2026; 107(1)DOI:10.1212/WNL.0000000000218159. PMID:42302218. IF:8.500(Q1/1D).

Min, YG, Llarch, P, Lleixà, C, Ju, W, Shin, HY, Ban, JJ, Querol, L, Sung, JJ. Development and Inter-Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2026; 31(3)DOI:10.1111/jns.70137. PMID:42437960. IF:3.200(Q2/4D).

Paciotti, M, Wagner, C, Frego, N, Beatrici, E, Mottaran, A, Bravi, CA, Piramide, F, Lores, MP, Sarchi, L, Piro, A, Farinha, R, Sorce, G, Balestrazzi, E, Nocera, L, Ruvolo, CC, Rebuffo, S, Liakos, N, Dell'Oglio, P, Wenzel, M, Moschovas, MC, Turri, F, Di Maida, F, Lambert, E, Wurnschimmel, C, De Groote, R, van Cleynenbreugel, B, Larcher, A, Andras, I, Buffi, NM, van der Poel, HG, Breda, A, Mottrie, A, Gallagher, AG. Ten-year update on the European Association of Urology Robotic Section (ERUS) fellowship training for robot-assisted radical prostatectomy. Bjui Compass. 2026; 7(7)DOI:10.1002/bco2.70227. PMID:42428668. IF:(Q/D).

Olguín-Hernández, Z, Hernández-Islas, A, Martínez-Andrade, GO, Fernández-Cortés, TL, Delgadillo-Badillo, E, Rojo-López, MI, Julve, J, Niño-Narvión, J, Calderón-Ramos, ZG, Ramírez-Moreno, E. Developing a digital assessment tool for childhood eating habits: a validation and reliability study in Mexican schoolchildren. Nutrire. 2026; 51(2)DOI:10.1186/s41110-026-00502-2. PMID:. IF:(Q/D).

Ulutekin, C, Can, A, Súkeníková, L, Querol, L, Juntas-Morales, R, Llauradó, A, Dietmann, A, Weiss, T, Latorre, D, Becher, B, Ingelfinger, F, Schreiner, B. Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome. JOURNAL OF MOLECULAR MEDICINE-JMM. 2026; 104(1)DOI:10.1007/s00109-026-02698-2. PMID:42399536. IF:4.200(Q1/3D).

D'Angelo, E, Kingsley, LG, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, BE, Prat, J. Mullerian adenosarcoma of the uterus, ovary and peritoneum: Whole transcriptomic digital spatial profiling (DSP) in a cohort of 42 tumors. HUMAN PATHOLOGY. 2026; 173DOI:10.1016/j.humpath.2026.106117. PMID:41932512. IF:2.600(Q2/4D).

Gilaberte, Y, Yélamos, O, Cañueto, J, Serra-Guillén, C, Conti, A, Pajuelo, F, Lecchi, A, Cappello, V, Kostov, B, Padullés, L, Romanelli, M. Patient-and Clinician-reported Outcomes, Safety and Efficacy Profile of Tirbanibulin 1% for Actinic Keratosis Under Conditions Close to Routine Clinical Practice in Spain and Italy (TIRBASKIN Study). Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104632. PMID:41864466. IF:(Q/D).

Tulleuda, R, Arias-Santiago, S, Armesto, S, Carrascosa, JM, Feltes, R, Pérez-Suárez, B, de la Cueva, P, López-Ferrer, A. Management of the Impact of Psoriasis on Sexuality: Consensus Recommendations From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104633. PMID:41864465. IF:(Q/D).

Jové-Blanco, A, Cotanda, CP, Gonzálvez, AA, Roset, MS, Capín, AM. Incorporation of the family perspective in the renewal of parent information sheets. Journal Of Healthcare Quality Research. 2026; 41(4)DOI:10.1016/j.jhqr.2026.101209. PMID:41950851. IF:(Q/D).

Saia, F, Lauck, S, Durand, E, Muir, DF, Spence, M, Vasa-Nicotera, M, Wood, D, Urbano-Carrillo, CA, Bouchayer, D, Iliescu, VA, Etienne, CS, Leclercq, F, Auffret, V, Asmarats, L, Di Mario, C, Veugeois, A, Maly, J, Schober, A, Nombela-Franco, L, Werner, N, Gómez-Hospital, JA, Mascherbauer, J, Musumeci, G, Meneveau, N, Meurice, T, Mahfoud, F, De Marco, F, Seidler, T, Leuschner, F, Joly, P, Collet, JP, Vogt, F, Di Lorenzo, E, Kuhn, E, Disdier, VP, McCalmont, G, Rakova, R, Wesselink, W, Kurucova, J, Hachaturyan, V, Lüske, CM, Bramlage, P, Frank, D. The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry. Clinical Research in Cardiology. 2026; 115(7)DOI:10.1007/s00392-025-02638-z. PMID:40261426. IF:3.700(Q1/3D).

Younossi, ZM, De Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, Tsochatzis, E, Trivikrama, SK, Balakumaran, LK, Fan, JG, Roberts, SK, Alswat, K, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, MG, Chan, WK, Fernandez, MIC, Duseja, A, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Alnaamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapé, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, The, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Segrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, A, Lam, B, Racila, A, Alqahtani, SA, Stepanova, M. Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study. HEPATOLOGY. 2026; 84(1)DOI:10.1097/HEP.0000000000001617. PMID:41231627. IF:15.800(Q1/1D).

Younossi, ZM, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, Tsochatzis, E, Trivikrama, SK, Balakumaran, LK, Fan, JG, Roberts, SK, Alswat, K, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, MG, Chan, WK, Fernandez, MIC, Duseja, A, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Alnaamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapé, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Kim-Jun, K, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Segrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, A, Lombardi, R, Lam, B, Racila, A, Alqahtani, SA, Stepanova, M. Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study. HEPATOLOGY. 2026; 84(1)DOI:10.1097/HEP.0000000000001564. PMID:41100867. IF:15.800(Q1/1D).

Varisco, B, Piovani, D, Del Turco, ER, Bussini, L, Paul, M, Sabik, EF, Castagna, A, Ripa, M, Gomes, MZR, Di Bella, S, Zerbato, V, Lopez, AB, Franceschini, E, Bandera, A, Oliva, A, Gavaruzzi, F, Muñoz, P, Mularoni, A, Seminari, E, Morelli, P, Pocaterra, D, Tascini, C, Papadimitriou-Olivgeris, M, Coppola, N, Cristini, F, Russo, A, Bassetti, M, Travi, G, Lopez-Contreras, J, Viale, P, Cento, V, Diella, L, Bavaro, DF, Gaibani, P, Giannella, M, Bartoletti, M. Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis. CLINICAL MICROBIOLOGY AND INFECTION. 2026; 32(7)DOI:10.1016/j.cmi.2026.02.019. PMID:41748017. IF:8.500(Q1/1D).

Heezen, LG, Mao, QR, Nicolau, S, Rausell, CN, van der Weerd, J, Kueckelhaus, J, Nath, RG, Manera, JD, Kan, HE, Niks, EH, van Putten, M, Aartsma-Rus, A, Flanigan, KM, Mahfouz, A, Spitali, P. Unraveling the spatial landscape of dystrophinopathies: a transcriptomic approach to Becker and Duchenne muscular dystrophies. JOURNAL OF PATHOLOGY. 2026; 269(3)DOI:10.1002/path.70067. PMID:42067897. IF:5.200(Q1/1D).

Pizarro-Galleguillos, B, Verdú-Diaz, J, Gómez-Andrés, D, Tobar, F, Montalba, C, Andia, M, Diaz-Manera, J, Jara, JD, Bevilacqua, JA. Visual mapping of muscle MRI fatty replacement patterns in genetic myopathies using dimensionality reduction. NEUROMUSCULAR DISORDERS. 2026; 64DOI:10.1016/j.nmd.2026.106464. PMID:42263369. IF:2.800(Q2/5D).

Sabater, L, Guasp, M, García, RR, Rondán, LN, Querol, L, Martín-Aguilar, L, Llarch, P, Balasa, M, Lladó, A, Painous, C, Compta, Y, Serafim, AB, Montini, A, Iranzo, A, Cano, JS, Dalmau, JO, Graus, F, Gaig, C. Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease. Neurology-Neuroimmunology & Neuroinflammation. 2026; 13(4)DOI:10.1212/NXI.0000000000200600. PMID:42241645. IF:7.500(Q1/1D).

Pena-Guzman, L, Bolano-Díaz, C, Lleixà, C, Querol, L, Trainor, C, Suetterlin, K, Straub, V, Díaz-Manera, J. Sensory neuronopathy secondary to gene therapy with AT845 for Pompe disease. NEUROMUSCULAR DISORDERS. 2026; 64DOI:10.1016/j.nmd.2026.106441. PMID:42142433. IF:2.800(Q2/5D).

Putri, VP, Samarasekera, N, Moullaali, TJ, Jampana, S, Aked, J, Åsberg, S, Schulman, S, Tsivgoulis, G, Pikilidou, M, Tsai, HH, Tsai, LK, Myint, PK, Pana, TA, Cordonnier, C, Casolla, B, Gaist, D, Pezzini, A, Camps-Renom, P, Klijn, CJM, Romoli, M, Tveiten, A, Liu, M, Xu, MM, Wu, B, Werring, D, Nash, PS, Banerjee, G, Li, LX, Salman, RAS. Rates and risk factors for major adverse cardiovascular and cerebrovascular events after stroke due to intracerebral hemorrhage: Systematic review and study-level meta-analysis. International Journal of Stroke. 2026; 21(6)DOI:10.1177/17474930261416692. PMID:41605872. IF:8.700(Q1/1D).

Majem, M, Mata, KM, Ibarguren, AM, Poves, MZ, Requena, C, Aparisi, FDA, Carrera, C, Cordellat, AB, Freites-Martinez, A, Sanmartin, O. Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology. Clinical & Translational Oncology. 2026; 28(7)DOI:10.1007/s12094-025-04209-0. PMID:41604110. IF:2.500(Q3/6D).

Rioja, P, Passarella, C, Angel, M, Valderrama, W, Ainaud, FB, Anguera, G, Gómez, V, Ruiz-Granados, A, Plata, D, Zapata, MI, Orta-Ruiz, A, Quiroga, MNG, Bourlon, MT, Grande, E, Kopp, RM, Molina-Cerrillo, J, Maroto, P, Sade, JP, Castellano, D. Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(7)DOI:10.1016/j.urolonc.2026.04.008. PMID:42139851. IF:2.300(Q2/5D).

Burotto, M, Zvirbule, Z, Alvarez, R, Chewaskulyong, B, Felip, E, Majem, M, Korbenfeld, E, Kolb-Sielecki, J, Isla, D, Barata, T, Bustillos, A, Herraez-Baranda, LA, Tosti, N, Young, F, Zanghi, J, Cappuzzo, F. Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies. LUNG CANCER. 2026; 217DOI:10.1016/j.lungcan.2026.109452. PMID:42214243. IF:4.400(Q1/2D).

Olivares-Ripoll, V, Lominchar, PL, Muñoz, P, Ballester, C, Diaz, D, Marrero, P, Cambeiro, L, Lopez, I, Vásquez, H, Casares, CM, Lopez, JAG, Asencio, JM. Are we managing desmoid tumors correctly in Spain? Results of the first national survey. CIRUGIA ESPANOLA. 2026; 104(7)DOI:10.1016/j.ciresp.2026.800333. PMID:. IF:1.300(Q3/7D).

Thwaites, DI, Jornet, N, Georg, D, Muren, L, Thorwarth, D, van Elmpt, W, Aznar, M, Knausl, B, Vedelago, J. A commemoration and appreciation of Professor Ben Mijnheer. RADIOTHERAPY AND ONCOLOGY. 2026; 220DOI:10.1016/j.radonc.2026.111586. PMID:42127568. IF:5.300(Q1/2D).

Martorell, A, Roldán, FA, García-Martínez, FJ, Leyva, AM, Ramírez, JCP, Vilarrasa, E. Spanish Clinical Management Guideline for Hidradenitis Suppurativa. Part I: Pathogenesis, Diagnosis, and Disease Staging. Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104639. PMID:41865977. IF:(Q/D).

Serra-Baldrich, E, Flórez, A, Manresa, MJ, de Frutos, FJO, Pereyra-Rodriguez, JJ, Pérez, B, Figueras, I. The State of the Art in Chronic Prurigo Nodularis. Dermatology and Therapy. 2026; 16(7)DOI:10.1007/s13555-026-01804-z. PMID:42247108. IF:4.200(Q1/1D).

Rubio-Briones, J, Ramos, FG, Sánchez, AM, Abadía, IB, Rodríguez, RM, Alcaraz, A, Legaz, MM, Lozano, F, Martín, MA, Cardo, AL, Rodríguez, VG, Velasco, JC, Liesa, MS, Pareja, CF, Ortiz, RE, de Torres, IG, Zalabardo, DS, Guijarro, A, Mengual, L, Borque-Fernando, A, Escaño, LME, Redorta, JP, Witjes, F, Piñeiro, LM. Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study. BJU INTERNATIONAL. 2026; 138(1)DOI:10.1111/bju.70230. PMID:41941336. IF:4.400(Q1/2D).

Lafont, PM, Pelaez, IM, Cuixart, CB. Long-term outcomes of COVID-19 in primary care: 5-Year follow-up of hospitalized and non-hospitalized patients in a population-based cohort study. Medicina De Familia-Semergen. 2026; 52(5)DOI:10.1016/j.semerg.2026.102781. PMID:42235195. IF:(Q/D).